MEDIFEMINA
0844.959.872 · rovalta.com · 25/09/2026
NORMAL SITUATION
MEDIFEMINA
Company — Normal situation.
Financial year 2024 · Closed on 30/09/2024
Net result7,2 k €+45,5 %over 1 year
Gross margin27,8 k €+15,6 %over 1 year
Equity60,3 k €+13,5 %over 1 year
Overview
Identity
Source · BCE/KBOMEDIFEMINA is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0844.959.872
- Legal form
- Private limited company
- Contributed capital
- 12 500,00 €
- Latest accounts
- 30/09/2024
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 12 filingsTrend over 12 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 27,8 k € | +15.6% | 24,1 k € | +32.4% | 18,2 k € | -33.0% | 27,2 k € | -4.6% | 28,5 k € |
| EBITDA | 26,4 k € | +16.2% | 22,7 k € | +34.7% | 16,9 k € | -36.4% | 26,5 k € | +5.9% | 25 k € |
| Operating result | 12,8 k € | +44.0% | 8,9 k € | +191% | 3,1 k € | -76.4% | 13 k € | -39.6% | 21,5 k € |
| Net result | 7,2 k € | +45.5% | 4,9 k € | +1185% | -453,6 € | -106% | 7,6 k € | -49.5% | 15 k € |
| Balance sheet | |||||||||
| Equity | 60,3 k € | +13.5% | 53,1 k € | +10.2% | 48,2 k € | -0.9% | 48,6 k € | +18.5% | 41 k € |
| Total assets | 108,8 k € | -3.1% | 112,4 k € | -6.9% | 120,6 k € | -9.8% | 133,7 k € | +93.3% | 69,2 k € |
| Cash | 38 k € | +7.6% | 35,3 k € | +24.5% | 28,3 k € | -1.8% | 28,9 k € | +16.4% | 24,8 k € |
| Debts | 48,6 k € | -18.0% | 59,3 k € | -18.2% | 72,5 k € | -14.9% | 85,1 k € | +202% | 28,2 k € |
Board of directors
Source · NBB, accounts to 30/09/20241 active · 1 ended
Active mandates
Aurore Lefere
ActiveEnded mandates
Aurore Lefere
EndedFinancials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 | 01/10/2018 |
| Closing of the financial year | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 | 30/09/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 06/12/2024 | 13/03/2024 | 19/03/2023 | 02/03/2022 | 02/03/2021 | 09/03/2020 |
| General meeting | 06/12/2024 | 05/03/2024 | 07/03/2023 | 01/03/2022 | 02/03/2021 | 03/03/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2024 | 06/12/2024 | 06/12/2024 | French | |
| Micro model | 30/09/2023 | 05/03/2024 | 13/03/2024 | French | |
| Micro model | 30/09/2022 | 07/03/2023 | 19/03/2023 | French | |
| Micro model | 30/09/2021 | 01/03/2022 | 02/03/2022 | French | |
| Micro model | 30/09/2020 | 02/03/2021 | 02/03/2021 | French | |
| Micro model | 30/09/2019 | 03/03/2020 | 09/03/2020 | French | |
| Micro model | 30/09/2018 | 05/03/2019 | 07/03/2019 | French | |
| Micro model | 30/09/2017 | 06/03/2018 | 09/03/2018 | French | |
| Abridged model | 30/09/2016 | 07/03/2017 | 23/03/2017 | French | |
| Abridged model | 30/09/2015 | 01/03/2016 | 31/03/2016 | French | |
| Abridged model | 30/09/2014 | 03/03/2015 | 10/03/2015 | French | |
| Abridged model | 30/09/2013 | 04/03/2014 | 17/03/2014 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20241 active · 1 ended
Active mandates
Aurore Lefere
ActiveEnded mandates
Aurore Lefere
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 20247,2 k €↑
- 2023Annual accounts 20234,9 k €↑
- 2022Annual accounts 2022-453,6 €↓
- 2021Annual accounts 20217,6 k €↓
- 2020Annual accounts 202015 k €↑
- 2019Annual accounts 201913 k €↑
- 2018Annual accounts 20189,8 k €↑
- 2017Annual accounts 201728,4 €↑
- 2016Annual accounts 2016-5,3 k €↓
- 2015Annual accounts 20152,8 k €↑
- 2014Annual accounts 2014-2,9 k €↑
- 2013Annual accounts 2013-3,8 k €